An interview with Dr Joshua Richter on his experience as an investigator for linvoseltamab-gcpt - by Reegan Burnell-Clarke (Commissioning Editor)

Joshua Richter

doi:10.1080/17474086.2026.2647574

An interview with Dr Joshua Richter on his experience as an investigator for linvoseltamab-gcpt - by Reegan Burnell-Clarke (Commissioning Editor)

Joshua Richter

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	583-584
Number of pages	2
Journal	Expert Review of Hematology
Volume	19
Issue number	6
DOIs	https://doi.org/10.1080/17474086.2026.2647574
State	Published - 1 Jun 2026

Access to Document

10.1080/17474086.2026.2647574

Cite this

@article{a828e2efaa464e06b867b7ce9cb5c4c5,

title = "An interview with Dr Joshua Richter on his experience as an investigator for linvoseltamab-gcpt - by Reegan Burnell-Clarke (Commissioning Editor)",

author = "Joshua Richter",

year = "2026",

month = jun,

day = "1",

doi = "10.1080/17474086.2026.2647574",

language = "English",

volume = "19",

pages = "583--584",

journal = "Expert Review of Hematology",

issn = "1747-4086",

publisher = "Taylor and Francis Ltd.",

number = "6",

}

TY - JOUR

T1 - An interview with Dr Joshua Richter on his experience as an investigator for linvoseltamab-gcpt - by Reegan Burnell-Clarke (Commissioning Editor)

AU - Richter, Joshua

PY - 2026/6/1

Y1 - 2026/6/1

UR - https://www.scopus.com/pages/publications/105040867519

U2 - 10.1080/17474086.2026.2647574

DO - 10.1080/17474086.2026.2647574

M3 - Article

C2 - 41851952

AN - SCOPUS:105040867519

SN - 1747-4086

VL - 19

SP - 583

EP - 584

JO - Expert Review of Hematology

JF - Expert Review of Hematology

IS - 6

ER -